DaltonTx

DaltonTx develops adaptive AI platforms to accelerate drug discovery for pharmaceutical and biotech organisations.

London, UK—Website

£4.0MTotal raised

DaltonTx builds adaptive, AI-enabled discovery platforms designed to integrate into pharmaceutical, biotechnology, and contract research workflows. The company aims to improve the economics and timelines of research and development for both small molecules and biologics.